To further portray intratumoral immunophenotypes according to genomic alterations of MTAP and CDKN2A, we evaluated the expression levels of the immune checkpoint molecule, PD-L1, and the key lymphokine that recruits tertiary lymphoid structures, CXCL13, in ccRCC samples with available genomic data from the discovery set of the FUSCC cohort. Here, MTAP is linked to nonpapillary renal cell carcinoma.